COVID-19 DIAGNOSTICS ________
LATERAL FLOW ANTIGEN TESTING
Rapid Test Ag 2019-nCov is a type of rapid diagnostic test used to detect the presence of the novel coronavirus (SARS-CoV-2) in individuals suspected of having COVID-19. Prognosis Biotech has developed the Rapid Test Ag 2019-nCov kits for the detection of SARS-CoV-2 antigen (nucleocapsid protein) in nasopharyngeal & nasal swab specimens.
This test is designed to rapidly identify infected individuals, enabling prompt clinical decisions and preventing potential virus outbreaks.
Rapid Test Ag 2019-nCov is an important tool in the fight against COVID-19 as it allows for quick and convenient testing of individuals who may have been exposed to the virus.
ProGnosis Biotech Rapid Test Ag 2019-nCov is designed to be non-invasive and does not require any special instrument or skill set and can be used in all types of premises where COVID-19 testing is required.
RAPID TEST ________
SARS-CoV-2 & INFLUENZA A_B
A SARS-CoV-2 & Influenza A/B rapid test is a diagnostic tool that is used to detect the presence of both the novel coronavirus (SARS-CoV-2) and influenza viruses (A and B) in a single test. This type of test is used to help diagnose individuals who are suspected of having COVID-19 or influenza, which can have similar symptoms, including fever, cough, and shortness of breath.
The SARS-CoV-2 & Influenza A/B rapid test works by detecting antigens (specific proteins) found on the surface of both viruses.
Prognosis Biotech has developed a new assay that allows medical professionals to provide rapid point-of-care testing and results for SARS-CoV-2 and/or Influenza A and B, from the same specimen on the same device.
With this Rapid Test the cause of flu-like symptoms can be identified, giving the answer to one of the most important questions nowadays, “Is it COVID-19 or just the flu?”.
RAPID TEST ________
INFLUENZA A_B
Influenza type A and B viruses are main cause of seasonal flu which account for millions of cases worldwide which could increase number of hospitalizations of those who are considered “at-risk”.
Prognosis Biotech has developed Influenza A/B rapid test that detects the presence or absence of influenza viruses (A and B) in a patient. This type of test is used to help diagnose individuals who are suspected of having the flu, which can cause symptoms such as fever, cough, body aches, and fatigue.
The Influenza A/B rapid test works by detecting antigens (specific proteins) found on the surface of the influenza viruses.
Accurate detection and diagnosis of the flu, within a few days of the symptom’s onset, is crucial for patients in order to begin treatment. The Prognosis Biotech Rapid Test FLU A_B is designed using a novel and rapid immunoassay technology, which offers fast and reliable results, allowing health care providers to confidently use it in a point-of-care setting.
rapid test ________
ADENOVIRUS
Adenoviruses are common in humans, usually cause respiratory illness while also being responsible for gastroenteritis, conjunctivitis, cystitis.
Symptoms of respiratory illness range from the common cold syndrome to pneumonia, affect all ages and do not show seasonal infection. Most serious infections occur in individuals who are immunocompromised and young children.
Prognosis Biotech Rapid Test Adenovirus is a qualitative immunoassay kit that helps laboratories and physicians detect the adenovirus antigen and confirm the diagnosis of adenovirus in patients with a respiratory illness.
rapid test ________
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Respiratory Syncytial Virus (RSV) is a highly contagious respiratory virus that can cause severe illness, especially in young children, elderly people, and those with weakened immune systems.
It is so common that most children have been infected with the virus by the age of two. In most cases it causes mild, cold-like symptoms, but for a small percentage, infection with RSV can lead to serious, sometimes life-threatening problems. Babies, young children, anyone with a weakened immune system and older adults are at greatest risk of severe infection.
Prognosis Biotech Rapid Test RSV is an immunoassay kit that helps medical professionals detect RSV protein and reach a quick diagnosis within minutes, making it a useful tool for diagnosing the virus quickly and enabling prompt treatment.
rapid test ________
STREPTOCOCCUS GROUP A (STREP-A)
The Rapid Test Strep A is a fast, easy to use and reliable diagnostic tool designed to quickly identify the presence of Group A Streptococcus (GAS) in throat swab samples in just 5 minutes. This test is crucial in the early detection and proper treatment of bacterial throat infections, most commonly known as strep throat.
Strep A, or Group A Streptococcus (GAS), is a type of bacteria that can cause various infections in humans, ranging from mild illnesses such as strep throat and impetigo to more severe conditions like rheumatic fever and invasive infections. Strep throat, the most common manifestation of a Strep A infection, is characterized by a sore throat, fever, and swollen lymph nodes. Early detection and treatment of Strep A infections are vital to prevent complications and reduce the risk of spreading the bacteria to others. The Rapid Test Strep A plays a crucial role in facilitating prompt diagnosis and effective treatment of these infections.
In 5 minutes only, the Rapid Test Strep A provides accurate results, helping healthcare professionals make timely decisions on patient treatment. This user-friendly test reduces the need for extensive laboratory work and helps prevent the unnecessary use of antibiotics, contributing to the global fight against antibiotic resistance.
The Rapid Test Strep A is a must-have tool for clinicians, enabling them to provide better patient care by diagnosing strep throat infections quickly and efficiently.
COVID-19 DIAGNOSTICS ________
LATERAL FLOW & ELISA ANTIBODY TESTING
Prognosis Biotech has developed the Rapid Test 2019-nCov Total Ig kits for the detection of SARS-CoV-2 Immunoglobulin antibodies in blood specimens.
This test is designed to detect a body’s immune response to SARS-CoV-2 (i.e., a past infection, not active infection) and comes in two different formats for application:
ELISA (Enzyme-linked immunosorbent assay) format made for testing laboratories. The following kits are available:
– Bio-Shield 2019-nCoV Total Immunoglobulins (IgA, IgG, IgM)
– Bio-Shield 2019-nCoV IgG
– Bio-Shield 2019-nCoV IgM
– Bio-Shield 2019-nCoV IgA
Rapid Lateral Flow format: an easy-to-use device with increased sensitivity that does not require any special instrument or skill set and can be used in all types of premises where COVID-19 testing is required.
COVID-19 DIAGNOSTICS ________
LATERAL FLOW ANTIGEN TESTING FOR SURFACES
The Rapid Surface Ag 2019-nCov is a rapid test for the detection of SARS-CoV-2 Nucleocapsid Protein Antigen (NP) in swabs of common surfaces, such as metal, plastic, glass, paper, and stainless steel. It is the first product for COVID-19 surface testing to utilize this innovative methodology.
The Rapid Surface Ag 2019-nCov is a valuable tool for several sectors enabling the companies to monitor and mitigate the spread of COVID-19 in their facilities and maintain a safe operating environment.
